A citation-based method for searching scientific literature

Cecilia L Speyer, Ali H Hachem, Ali A Assi, Jennifer S Johnson, John A DeVries, David H Gorski. PLoS One 2014
Times Cited: 37







List of co-cited articles
237 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
Cecilia L Speyer, Jennifer S Smith, Malathi Banda, John A DeVries, Tassia Mekani, David H Gorski. Breast Cancer Res Treat 2012
87
59

Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
Pamela M Pollock, Karine Cohen-Solal, Raman Sood, Jin Namkoong, Jeffrey J Martino, Aruna Koganti, Hua Zhu, Christiane Robbins, Izabela Makalowska, Seung-Shick Shin,[...]. Nat Genet 2003
220
37

Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Chi Zhang, Xian-rui Yuan, Hao-yu Li, Zi-jin Zhao, Yi-wei Liao, Xiang-yu Wang, Jun Su, Shu-shan Sang, Qing Liu. Cell Physiol Biochem 2015
50
32

Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.
Cecilia L Speyer, Mahdy A Nassar, Ali H Hachem, Miriam A Bukhsh, Waris S Jafry, Rafa M Khansa, David H Gorski. Breast Cancer Res Treat 2016
26
46

Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
Yu Wen, Jiadong Li, Jasmine Koo, Seung-Shick Shin, Yong Lin, Byeong-Seon Jeong, Janice M Mehnert, Suzie Chen, Karine A Cohen-Sola, James S Goydos. Cancer Res 2014
32
34

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
Jin Namkoong, Seung-Shick Shin, Hwa Jin Lee, Yarí E Marín, Brian A Wall, James S Goydos, Suzie Chen. Cancer Res 2007
143
29

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.
Malathi Banda, Cecilia L Speyer, Sara N Semma, Kingsley O Osuala, Nicole Kounalakis, Keila E Torres Torres, Nicola J Barnard, Hyunjin J Kim, Bonnie F Sloane, Fred R Miller,[...]. PLoS One 2014
28
39

Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.
Jessica L F Teh, Raj Shah, Stephanie La Cava, Sonia C Dolfi, Madhura S Mehta, Sameera Kongara, Sandy Price, Shridar Ganesan, Kenneth R Reuhl, Kim M Hirshfield,[...]. Breast Cancer Res Treat 2015
20
55

Metabotropic glutamate receptors in cancer.
Lumeng J Yu, Brian A Wall, Janet Wangari-Talbot, Suzie Chen. Neuropharmacology 2017
55
29

Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.
Kyu Yeong Choi, Kai Chang, James M Pickel, John D Badger, Katherine W Roche. Proc Natl Acad Sci U S A 2011
67
27

Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance.
Hee Jin Chang, Byong Chul Yoo, Seok-Byung Lim, Seung-Yong Jeong, Woo Ho Kim, Jae-Gahb Park. Clin Cancer Res 2005
92
27

Expression of glutamate receptor subunits in human cancers.
Andrzej Stepulak, Hella Luksch, Christine Gebhardt, Ortrud Uckermann, Jenny Marzahn, Marco Sifringer, Wojciech Rzeski, Christian Staufner, Katja S Brocke, Lechoslaw Turski,[...]. Histochem Cell Biol 2009
131
24

Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo.
Atif J Khan, Brian Wall, Stuti Ahlawat, Camille Green, Devora Schiff, Janice M Mehnert, James S Goydos, Suzie Chen, Bruce G Haffty. Clin Cancer Res 2011
34
26

Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma.
So-Yeon Park, Seoung-Ae Lee, In-Hee Han, Byong-Chul Yoo, Seung-Hoon Lee, Jo-Yong Park, In-Ho Cha, Jin Kim, Sung-Weon Choi. Oncol Rep 2007
47
24

A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma.
Dana Yip, Maithao N Le, Joseph L-K Chan, Jonathan H Lee, Janice A Mehnert, Anthony Yudd, Jeffery Kempf, Weichung J Shih, Suzie Chen, James S Goydos. Clin Cancer Res 2009
79
21

Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
J J Martino, B A Wall, E Mastrantoni, B J Wilimczyk, S N La Cava, K Degenhardt, E White, S Chen. Oncogene 2013
48
21

Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.
Seung-Shick Shin, Jin Namkoong, Brian A Wall, Ryan Gleason, Hwa Jin Lee, Suzie Chen. Pigment Cell Melanoma Res 2008
65
21

Glutamate release promotes growth of malignant gliomas.
T Takano, J H Lin, G Arcuino, Q Gao, J Yang, M Nedergaard. Nat Med 2001
388
21

Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.
Brian A Wall, Janet Wangari-Talbot, Seung S Shin, Devora Schiff, Jairo Sierra, Lumeng J Yu, Atif Khan, Bruce Haffty, James S Goydos, Suzie Chen. Pigment Cell Melanoma Res 2014
18
44

Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
Antonietta Arcella, Giulia Carpinelli, Giuseppe Battaglia, Mara D'Onofrio, Filippo Santoro, Richard Teke Ngomba, Valeria Bruno, Paola Casolini, Felice Giangaspero, Ferdinando Nicoletti. Neuro Oncol 2005
85
21

Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells.
Mara D'Onofrio, Antonietta Arcella, Valeria Bruno, Richard T Ngomba, Giuseppe Battaglia, Vincenza Lombari, Giuseppe Ragona, Antonella Calogero, Ferdinando Nicoletti. J Neurochem 2003
68
21

The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.
Maithao N Le, Joseph L-K Chan, Stephen A Rosenberg, Adam S Nabatian, Kim T Merrigan, Karine A Cohen-Solal, James S Goydos. J Invest Dermatol 2010
52
21

Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Colleen M Niswender, P Jeffrey Conn. Annu Rev Pharmacol Toxicol 2010
21

Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.
Hwa Jin Lee, Brian A Wall, Janet Wangari-Talbot, Seung-Shick Shin, Stephen Rosenberg, Joseph L-K Chan, Jin Namkoong, James S Goydos, Suzie Chen. Clin Cancer Res 2011
56
18

Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.
Y Ohtani, T Harada, Y Funasaka, K Nakao, C Takahara, M Abdel-Daim, N Sakai, N Saito, C Nishigori, A Aiba. Oncogene 2008
61
18

Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.
Yarí E Marín, Jin Namkoong, Karine Cohen-Solal, Seung-Shick Shin, Jeffrey J Martino, Masahiro Oka, Suzie Chen. Cell Signal 2006
65
18


Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.
Madhura S Mehta, Sonia C Dolfi, Roman Bronfenbrener, Erhan Bilal, Chunxia Chen, Dirk Moore, Yong Lin, Hussein Rahim, Seena Aisner, Romona D Kersellius,[...]. PLoS One 2013
19
36

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.
C Ciceroni, M Bonelli, E Mastrantoni, C Niccolini, M Laurenza, L M Larocca, R Pallini, A Traficante, P Spinsanti, L Ricci-Vitiani,[...]. Cell Death Differ 2013
47
18

Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer.
Rachel E Sexton, Ali H Hachem, Ali A Assi, Miriam A Bukhsh, David H Gorski, Cecilia L Speyer. Sci Rep 2018
12
58

Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells.
Brian A Wall, Lumeng J Yu, Atif Khan, Bruce Haffty, James S Goydos, Suzie Chen. Pigment Cell Melanoma Res 2015
13
46

Development of heritable melanoma in transgenic mice.
H Zhu, K Reuhl, X Zhang, R Botha, K Ryan, J Wei, S Chen. J Invest Dermatol 1998
63
16

Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas.
Luisa Iacovelli, Antonietta Arcella, Giuseppe Battaglia, Simonetta Pazzaglia, Eleonora Aronica, Paola Spinsanti, Alessandra Caruso, Enrico De Smaele, Anna Saran, Alberto Gulino,[...]. J Neurosci 2006
65
16

Spontaneous melanocytosis in transgenic mice.
S Chen, H Zhu, W J Wetzel, M A Philbert. J Invest Dermatol 1996
49
16

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
Janice M Mehnert, Ann W Silk, J H Lee, Liesel Dudek, Byeong-Seon Jeong, Jiadong Li, Jason M Schenkel, Evita Sadimin, Michael Kane, Hongxia Lin,[...]. Pigment Cell Melanoma Res 2018
29
20

Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
Byong Chul Yoo, Eunkyung Jeon, Sung-Hye Hong, Young-Kyoung Shin, Hee Jin Chang, Jae-Gahb Park. Clin Cancer Res 2004
56
16

AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).
Seung-Shick Shin, Brian A Wall, James S Goydos, Suzie Chen. Pigment Cell Melanoma Res 2010
37
16

Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells.
Shahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, Kristopher Attwood, Ray Scioneaux, Dhatchayini Subramani, Charles Manhardt, Giovanni D Lorusso, Stacey S Willard, Hillary Thompson,[...]. Clin Cancer Res 2012
90
16

Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
C Ciceroni, A Arcella, P Mosillo, G Battaglia, E Mastrantoni, M A Oliva, G Carpinelli, F Santoro, P Sale, L Ricci-Vitiani,[...]. Neuropharmacology 2008
36
16

Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.
Sonia C Dolfi, Daniel J Medina, Aparna Kareddula, Bhavna Paratala, Ashley Rose, Jatinder Dhami, Suzie Chen, Shridar Ganesan, Gillian Mackay, Alexei Vazquez,[...]. Oncotarget 2017
14
42




Glutamatergic signaling in cellular transformation.
Jessica L F Teh, Suzie Chen. Pigment Cell Melanoma Res 2012
38
13

Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.
Todd D Prickett, Xiaomu Wei, Isabel Cardenas-Navia, Jamie K Teer, Jimmy C Lin, Vijay Walia, Jared Gartner, Jiji Jiang, Praveen F Cherukuri, Alfredo Molinolo,[...]. Nat Genet 2011
111
13

The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells.
Nikolaos Pissimissis, Efstathia Papageorgiou, Peter Lembessis, Athanasios Armakolas, Michael Koutsilieris. Anticancer Res 2009
41
13

Glutamate receptors in pediatric tumors of the central nervous system.
Katja S Brocke, Christian Staufner, Hella Luksch, Kathrin D Geiger, Andrzej Stepulak, Jenny Marzahn, Gabriele Schackert, Achim Temme, Chrysanthy Ikonomidou. Cancer Biol Ther 2010
47
13

Glutamate receptors in laryngeal cancer cells.
Andrzej Stepulak, Hella Luksch, Ortrud Uckermann, Marco Sifringer, Wojciech Rzeski, Krzysztof Polberg, Krzysztof Kupisz, Janusz Klatka, Michal Kielbus, Aneta Grabarska,[...]. Anticancer Res 2011
20
25

Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression.
Stephen A Rosenberg, Scot A Niglio, Negar Salehomoum, Joseph L-K Chan, Byeong-Seon Jeong, Yu Wen, Jiadong Li, Jami Fukui, Suzie Chen, Seung-Shick Shin,[...]. Transl Oncol 2015
17
29

mGlu Receptors and Cancerous Growth.
Jessica Teh, Suzie Chen. Wiley Interdiscip Rev Membr Transp Signal 2012
24
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.